NANOBIOTIX to Announce First Quarter 2022 Financial Results

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News:NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that it will report its financial result...

Related Keywords

Germany , New York , United States , Paris , France General , France , Texas , Massachusetts , Cambridge , Cambridgeshire , United Kingdom , Canada , Spain , Brandon Owens , Kate Mcneil , Pierre Louis Germain , Bart Van Rhijn , Linkedin , French Financial Markets Authority Autorit , Communications Department , University Of Texas Md Anderson Cancer Center , Live International , Twitter , Investor Relations Department , Drug Administration , Nasdaq , Exchange Commission , Given The Company , Euronext , Regulatory News , Laurent Levy , Event Plus Passcode , Plus Passcode , United States Food , Fast Track , Cancer Center , Nasdaq Global Select Market , New York City , Private Securities Litigation Reform Act , Annual Report , French Financial Markets Authority , Des March , Half Year Financial Report ,